1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Onconetix, Inc.

Onconetix, Inc.

ONCO
Onconetix, Inc.US flagNASDAQ Capital Market
1.09
USD
-0.05
- -
364,092.00Market Cap

Total Valuation

Onconetix, Inc. carries a market capitalization of 364,092.00, placing it among publicly traded companies globally. Its enterprise value stands at -2.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap364,092.00
Enterprise Value-2.92M

Share Statistics

Onconetix, Inc. currently has 275,515.00 shares outstanding.

Shares Outstanding275,515.00
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.69, and the price-to-book ratio stands at 0.00.

PE RatioN/A
PS Ratio0.69
PB Ratio0.00
P/TBV Ratio0.33
P/FCF Ratio-0.05
P/OCF Ratio-0.05

Enterprise Valuation

EV / Sales11.45
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Onconetix, Inc. maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.47, indicating elevated leverage, while an interest coverage ratio of -12.78 demonstrates limited ability to service its debt obligations.

Current Ratio1.41
Quick Ratio1.24
Debt / Equity2.47
Debt / EBITDA-0.04
Interest Coverage-12.78

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-57.73
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)10.69
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.02

Taxes

Over the trailing twelve months, Onconetix, Inc. has paid 525.00 in income taxes, reflecting an effective tax rate of 0.01.

Income Tax525.00
Effective Tax Rate0.01

Stock Price Statistics

Onconetix, Inc.'s stock has declined approximately -99.6512% over the past 52 weeks. The 50-day moving average sits at 8.71, while the 200-day moving average is 85.16.

Beta (5Y)N/A
52-Week Price Change-99.6512%
50-Day Moving Average8.71
200-Day Moving Average85.16
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Onconetix, Inc. generated 735,198.00 in revenue and converted that into -9.70M in net income, yielding earnings per share of -284.46. EBITDA reached -6.77M, while operating income came in at -6.78M.

Revenue735,198.00
Gross Profit585,426.00
Operating Income-6.78M
Pretax Income-9.70M
Net Income-9.70M
EBITDA-6.77M
EBIT-6.78M
Earnings Per Share (EPS)-284.46

Balance Sheet

Onconetix, Inc. holds 3.72M in cash and equivalents against 289,922.00 in total debt, resulting in a net debt position of -3.47M. Total book value stands at -135.43M, with working capital of 1.26M providing operational flexibility.

Cash & Cash Equivalents3.72M
Total Debt289,922.00
Net Debt-3.47M
Equity (Book Value)-135.43M
Book Value Per Share-3,971.03
Working Capital1.26M

Cash Flow

Onconetix, Inc. produced -9.80M in operating cash flow over the past twelve months.

Operating Cash Flow-9.80M
Capital ExpendituresN/A
Free Cash Flow-9.80M
FCF Per Share-287.36

Margins

Onconetix, Inc. operates with a gross margin of 79.63, reflecting its pricing power and cost economics. The operating margin of -922.72 and net profit margin of -1,319.55 provide insight into operational efficiency.

Gross Margin79.63
Operating Margin-922.72
Pretax Margin-1,319.48
Profit Margin-1,319.55
EBITDA Margin-920.57

Dividends & Yields

The company's payout ratio of 3.28 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio3.28
Shareholder Yield-2,403.64
FCF Yield-1,928.58

Stock Splits

Onconetix, Inc.'s most recent stock split took place on May 21, 2026 with a 10:1 split ratio.

Last Split Date5/21/2026
Split Ratio10:1

Scores

Onconetix, Inc. posts an Altman Z-Score of -45.21, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-45.21